Published in Cancer Weekly, May 4th, 2004
Abstract #1602, which describes MG98 activity against gastric cancer, was presented by MethylGene, Inc., a private biopharmaceutical company focused on developing new drugs for cancer and infectious diseases. Abstract #1609, which describes the activity of MG98 in combination with interferon against renal cancer cells was presented by...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.